IRIS
MARASCIO, Nadia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.660
AS - Asia 1.888
EU - Europa 1.087
SA - Sud America 369
AF - Africa 34
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.578
SG - Singapore 896
IT - Italia 560
CN - Cina 401
BR - Brasile 273
VN - Vietnam 197
IN - India 185
DE - Germania 145
GB - Regno Unito 77
SE - Svezia 70
FI - Finlandia 67
CA - Canada 49
HK - Hong Kong 43
AR - Argentina 40
NL - Olanda 30
MX - Messico 23
CZ - Repubblica Ceca 22
FR - Francia 21
BD - Bangladesh 19
TR - Turchia 18
ES - Italia 15
IQ - Iraq 15
JP - Giappone 14
PL - Polonia 14
VE - Venezuela 14
PK - Pakistan 12
ZA - Sudafrica 12
ID - Indonesia 11
UZ - Uzbekistan 11
CL - Cile 9
EC - Ecuador 9
RO - Romania 9
RU - Federazione Russa 8
AT - Austria 7
IR - Iran 7
MT - Malta 7
PE - Perù 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
IL - Israele 5
PH - Filippine 5
SA - Arabia Saudita 5
UA - Ucraina 5
UY - Uruguay 5
AZ - Azerbaigian 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
SN - Senegal 4
TH - Thailandia 4
AL - Albania 3
CH - Svizzera 3
CR - Costa Rica 3
HR - Croazia 3
IE - Irlanda 3
LV - Lettonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
PT - Portogallo 2
TN - Tunisia 2
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BS - Bahamas 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
KH - Cambogia 1
KI - Kiribati 1
LK - Sri Lanka 1
MA - Marocco 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 6.041
Salva come PNG Salva come JPEG
Città #
San Jose 593
Singapore 339
Ashburn 327
Dallas 194
Chandler 180
Santa Clara 154
Bengaluru 138
Hefei 138
Milan 110
Munich 105
Lawrence 92
Princeton 92
Beijing 60
Chicago 59
Ho Chi Minh City 59
Wilmington 55
London 53
Hanoi 50
Turku 50
Rome 48
Hong Kong 41
Boardman 37
Los Angeles 33
São Paulo 31
Ottawa 27
Des Moines 22
New York 22
Olomouc 21
Crotone 20
Catanzaro 19
Florence 18
San Francisco 18
Brooklyn 16
Helsinki 16
Palermo 15
Chennai 14
Norwalk 13
Tokyo 13
Naples 12
Haiphong 11
Council Bluffs 10
Da Nang 10
San Nicola Manfredi 10
Warsaw 10
Padova 9
Tashkent 9
Baghdad 8
Mexico City 8
Orem 8
Shanghai 8
Atlanta 7
Boston 7
Brasília 7
Ninh Bình 7
Porto Alegre 7
Taranto 7
Amsterdam 6
Assago 6
Bari 6
Cosenza 6
Curitiba 6
Guayaquil 6
Johannesburg 6
Lyon 6
Maryland Heights 6
Miami 6
Montreal 6
Phoenix 6
Redwood City 6
Salvador 6
St Louis 6
Caracas 5
Casalnuovo di Napoli 5
Dhaka 5
Guangzhou 5
Hanover 5
Lima 5
Pune 5
Rende 5
Shenzhen 5
Thái Bình 5
Ankara 4
Biên Hòa 4
Cape Town 4
Charlotte 4
Dakar 4
Denver 4
Fortaleza 4
Lahore 4
Latina 4
Manchester 4
Monheim 4
Montevideo 4
Nuremberg 4
Pisa 4
Queens 4
Reggio Calabria 4
Rio das Ostras 4
Rio de Janeiro 4
Seattle 4
Totale 3.663
Salva come PNG Salva come JPEG
Nome #
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 132
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 92
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 89
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 83
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 81
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 77
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 74
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 74
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 70
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 69
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 69
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 67
Citrus bergamia: Kinetics of Antimicrobial Activity on Clinical Isolates 67
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 66
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 66
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 64
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 64
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 62
SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion 62
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 62
31st International papillomavirus conference Cape Town, 28 Febbraio - 4 Marzo 2017. 61
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 59
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 58
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 58
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 56
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 56
Virological Mechanisms in the Coinfection between HIV and HCV 55
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 55
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 54
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 53
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 53
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 52
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes 52
An Ascaris lumbricoides infection diagnosed by colonoscopy: A case report and a brief literature review 51
Outcome of hbv screening and vaccination in a migrant population in southern italy 50
Diagnostic and prognostic evaluation of soluble CD14 subtype for sepsis in critically ill patients: a preliminary study 50
Identification of pmrB mutations as putative mechanism for colistin resistance in A. baumannii strains isolated after in vivo colistin exposure. 50
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4 49
Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients 49
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 49
Integrating Digital Health Solutions with Immunization Strategies: Improving Immunization Coverage and Monitoring in the Post-COVID-19 Era 48
Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression 48
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 48
Chapter: Next-generation sequencing and microbiome evaluation: Molecular microbiology and its impact on human health 48
Changing epidemiology of hepatitis C in Italy: a population-based survey in a historically high endemic area 48
The issue of climate change and the spread of tropical diseases in Europe and Italy: vector biology, disease transmission, genome-based monitoring and public health implications. 47
Changing and Evolution of Influenza Virus: Is It a Trivial Flu? 47
Prevalence of Enteric Pathogens and Antibiotic Resistance: Results of a Six-Year Active Surveillance Study on Patients Admitted to a Teaching Hospital 46
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 45
Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy. 44
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota 44
Aspetti clinici ed epidemiologici dell’infezione da genotipo 4 di HCV 44
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 44
Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy 44
Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level 44
Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients 43
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients 42
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 42
Efflux Pump AdeABC Assessment in Acinetobacter baumannii Strains Isolated in a Teaching Hospital 42
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 42
Cat-Scratch Diseases (CSD) con coinvolgimento splenico multifocale in paziente immunocompetente: contributo della diagnosi molecolare 42
Next Generation Sequencing and Microbiome Evaluation: Molecular Microbiology and Its Impact on Human Health 42
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 41
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 41
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson's disease model 41
Molecular characterization of autochthonous Hepatitis E virus detected from a human acute infection in the Calabria Region, Southern Italy 41
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges. 41
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 40
SOLUBLE CD14 SUBTYPE - A NEW BIOMARKER IN PREDICTING OUTCOME OF CRITICALLY ILL SEPTIC PATIENTS: AN OBSERVATIONAL PROSPECTIVE STUDY. 40
Risk factors for hepatitis B and C among healthy population: a community-based survey from four districts of Southern Italy 40
Does the Human Gut Virome Contribute to Host Health or Disease? 39
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy 39
Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy 39
Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients 39
Data presentation HCV virology 39
Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing. 39
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 38
Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital 38
OMIC INSIGHTS INTO VARIOUS CEFTAZIDIME-AVIBACTAM-RESISTANT KLEBSIELLA PNEUMONIAE ISOLATES FROM TWO SOUTHERN ITALIAN REGIONS 38
Diagnosis and follow-up of Bartonella henselae infection in the spleen of an immunocompetent patient by real-time quantitative PCR 38
Ultra-deep sequencing and bioinformatics approach to detect natural resistance-associated variants in DAA-naïve HCV positive patients 38
Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy). 38
MOLECULAR CHARACTERIZATION AND CLUSTER ANALYSIS OF SARS-COV-2 VIRAL ISOLATES IN KAHRAMANMARAŞ CITY, TURKEY: THE DELTA VOC WAVE WITHIN ONE MONTH 37
Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy 37
Molecular identification of Bartonella quintana infection using species-specific real-time PCR targeting transcriptional regulatory protein (bqtR) gene. 37
Role of IgG and IgM and proinflammatory non-specific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 37
The Spread of SARS-CoV-2 Omicron Variant in CALABRIA: A Spatio-Temporal Report of Viral Genome Evolution 36
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study (BMC Infectious Diseases, (2022), 22, 1, (793), 10.1186/s12879-022-07774-9) 36
ROLE OF TREG, BREG AND OTHER CYTOKINE SETS IN HOST PROTECTION AND IMMUNOPATHOLOGY DURING HUMAN LEISHMANIASIS: ARE THEY POTENTIAL VALUABLE MARKERS IN CLINICAL SETTINGS AND VACCINE EVALUATION? 36
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study. 36
Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients. 36
Six years genotype distribution of Human Papillomavirus in Calabria Region, Southern Italy: a retrospective study. 36
Diagnosis and follow-up of Bartonella henselae infection in the spleen of an immunocompetent patient by real-time quantitative PCR 36
Presepsin: a possible sepsis marker for critically ill patients? 36
Update on HPV epidemiology in Calabria Region, Southern Italy. 36
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 35
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies 35
Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria region 35
Prevalenza di HCV3 ed HCV4 nella nuova era degli antivirali ad azione diretta (DAA) 34
Totale 5.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.873
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 7 0 1
2021/2022269 3 1 0 70 5 2 24 59 26 22 53 4
2022/2023638 196 59 17 54 41 44 19 28 76 33 57 14
2023/2024454 74 63 20 30 26 86 13 24 15 20 37 46
2024/20251.460 197 57 36 61 131 158 43 45 165 16 220 331
2025/20263.180 206 384 273 424 358 164 510 193 445 223 0 0
Totale 6.237